BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36029589)

  • 1. Cytokeratin 10 (CK10) expression in cancer: A tissue microarray study on 11,021 tumors.
    Uhlig R; Abboud M; Gorbokon N; Lennartz M; Dwertmann Rico S; Kind S; Reiswich V; Viehweger F; Kluth M; Hube-Magg C; Bernreuther C; Büscheck F; Clauditz TS; Fraune C; Hinsch A; Jacobsen F; Krech T; Lebok P; Steurer S; Burandt E; Minner S; Marx A; Simon R; Sauter G; Menz A
    Ann Diagn Pathol; 2022 Oct; 60():152029. PubMed ID: 36029589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokeratin 13 (CK13) expression in cancer: a tissue microarray study on 10,439 tumors.
    Lennartz M; Ullmann VS; Gorbokon N; Uhlig R; Rico SD; Kind S; Reiswich V; Viehweger F; Kluth M; Hube-Magg C; Bernreuther C; Büscheck F; Putri D; Clauditz TS; Fraune C; Hinsch A; Jacobsen F; Krech T; Lebock P; Steurer S; Burandt E; Minner S; Marx AH; Simon R; Sauter G; Menz A
    APMIS; 2023 Feb; 131(2):77-91. PubMed ID: 36269681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desmoglein 3 (Dsg3) expression in cancer: A tissue microarray study on 15,869 tumors.
    Viehweger F; Azem A; Gorbokon N; Uhlig R; Lennartz M; Dwertmann Rico S; Kind S; Reiswich V; Kluth M; Hube-Magg C; Bernreuther C; Büscheck F; Clauditz TS; Fraune C; Jacobsen F; Krech T; Lebok P; Steurer S; Burandt E; Minner S; Marx AH; Simon R; Sauter G; Menz A; Hinsch A
    Pathol Res Pract; 2022 Dec; 240():154200. PubMed ID: 36375372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokeratin expression in non-neoplastic oesophageal epithelium and squamous cell carcinoma of the oesophagus.
    Lam KY; Loke SL; Shen XC; Ma LT
    Virchows Arch; 1995; 426(4):345-9. PubMed ID: 7541275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokeratins and lung carcinomas.
    Nhung NV; Mirejovský P; Mirejovský T; Melínová L
    Cesk Patol; 1999 Jul; 35(3):80-4. PubMed ID: 11038661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung.
    Chang A; Amin A; Gabrielson E; Illei P; Roden RB; Sharma R; Epstein JI
    Am J Surg Pathol; 2012 Oct; 36(10):1472-6. PubMed ID: 22982890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors.
    Menz A; Weitbrecht T; Gorbokon N; Büscheck F; Luebke AM; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Weidemann S; Fraune C; Möller K; Bernreuther C; Lebok P; Clauditz T; Sauter G; Uhlig R; Wilczak W; Steurer S; Minner S; Burandt E; Krech R; Dum D; Krech T; Marx A; Simon R
    Mol Med; 2021 Feb; 27(1):16. PubMed ID: 33588765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas.
    Parker DC; Folpe AL; Bell J; Oliva E; Young RH; Cohen C; Amin MB
    Am J Surg Pathol; 2003 Jan; 27(1):1-10. PubMed ID: 12502922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokeratin 14 as a marker of squamous differentiation in transitional cell carcinomas.
    Harnden P; Southgate J
    J Clin Pathol; 1997 Dec; 50(12):1032-3. PubMed ID: 9516889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pan-keratin Immunostaining in Human Tumors: A Tissue Microarray Study of 15,940 Tumors.
    Menz A; Gorbokon N; Viehweger F; Lennartz M; Hube-Magg C; Hornsteiner L; Kluth M; Völkel C; Luebke AM; Fraune C; Uhlig R; Minner S; Dum D; Höflmayer D; Sauter G; Simon R; Burandt E; Clauditz TS; Lebok P; Jacobsen F; Steurer S; Krech T; Marx AH; Bernreuther C
    Int J Surg Pathol; 2023 Sep; 31(6):927-938. PubMed ID: 35946088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of GATA-3 and Cytokeratin 5/6 Immunostains in Separating Condyloma Acuminatum Arising in the Urinary Tract From Non-Invasive Papillary Urothelial Carcinoma.
    Montoya-Cerrillo D; Briski LM; Jorda M; Kryvenko ON
    Int J Surg Pathol; 2022 May; 30(3):260-264. PubMed ID: 34665053
    [No Abstract]   [Full Text] [Related]  

  • 12. TRPS1 is a Highly Sensitive Marker for Breast Cancer: A Tissue Microarray Study Evaluating More Than 19,000 Tumors From 152 Different Tumor Entities.
    Lennartz M; Löhr N; Höflmayer D; Dwertmann Rico S; von Bargen C; Kind S; Reiswich V; Viehweger F; Lutz F; Bertram V; Fraune C; Gorbokon N; Weidemann S; Blessin NC; Hube-Magg C; Menz A; Schlichter R; Krech T; Hinsch A; Burandt E; Sauter G; Simon R; Kluth M; Marx AH; Lebok P; Dum D; Minner S; Jacobsen F; Clauditz TS; Bernreuther C; Steurer S
    Am J Surg Pathol; 2024 Jun; 48(6):637-651. PubMed ID: 38647255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokeratin 5 and cytokeratin 6 expressions are unconnected in normal and cancerous tissues and have separate diagnostic implications.
    Völkel C; De Wispelaere N; Weidemann S; Gorbokon N; Lennartz M; Luebke AM; Hube-Magg C; Kluth M; Fraune C; Möller K; Bernreuther C; Lebok P; Clauditz TS; Jacobsen F; Sauter G; Uhlig R; Wilczak W; Steurer S; Minner S; Krech RH; Dum D; Krech T; Marx AH; Simon R; Burandt E; Menz A
    Virchows Arch; 2022 Feb; 480(2):433-447. PubMed ID: 34559291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors.
    Steurer S; Riemann C; Büscheck F; Luebke AM; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Weidemann S; Fraune C; Möller K; Menz A; Fisch M; Rink M; Bernreuther C; Lebok P; Clauditz TS; Sauter G; Uhlig R; Wilczak W; Dum D; Simon R; Minner S; Burandt E; Krech R; Krech T; Marx AH
    Biomark Res; 2021 Jan; 9(1):7. PubMed ID: 33494829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GATA3 Expression in Human Tumors: A Tissue Microarray Study on 16,557 Tumors.
    Reiswich V; Schmidt CE; Lennartz M; Höflmayer D; Hube-Magg C; Weidemann S; Fraune C; Büscheck F; Möller K; Bernreuther C; Simon R; Clauditz TS; Blessin NC; Bady E; Sauter G; Uhlig R; Steurer S; Minner S; Burandt E; Dum D; Marx AH; Krech T; Lebok P; Hinsch A; Jacobsen F
    Pathobiology; 2023; 90(4):219-232. PubMed ID: 36649695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokeratin expression in squamous cell carcinoma of the lung and oral cavity: an immunohistochemical study with possible clinical relevance.
    Hamakawa H; Bao Y; Takarada M; Fukuzumi M; Tanioka H
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Apr; 85(4):438-43. PubMed ID: 9574953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray.
    Reis-Filho JS; Simpson PT; Martins A; Preto A; Gärtner F; Schmitt FC
    Virchows Arch; 2003 Aug; 443(2):122-32. PubMed ID: 12884041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cd44: a marker of squamous differentiation in adenosquamous neoplasms.
    Ylagan LR; Scholes J; Demopoulos R
    Arch Pathol Lab Med; 2000 Feb; 124(2):212-5. PubMed ID: 10656728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics and immunohistochemistry define some of the steps involved in the squamous differentiation of the bladder transitional epithelium: a novel strategy for identifying metaplastic lesions.
    Celis JE; Celis P; Ostergaard M; Basse B; Lauridsen JB; Ratz G; Rasmussen HH; Orntoft TF; Hein B; Wolf H; Celis A
    Cancer Res; 1999 Jun; 59(12):3003-9. PubMed ID: 10383167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MN antigen expression in normal, preneoplastic, and neoplastic esophagus: a clinicopathological study of a new cancer-associated biomarker.
    Turner JR; Odze RD; Crum CP; Resnick MB
    Hum Pathol; 1997 Jun; 28(6):740-4. PubMed ID: 9191010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.